UBS raised the firm’s price target on Cencora (COR) to $380 from $350 and keeps a Buy rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COR:
- Trump Trade: Trump administration prepares new probe into pharma prices
- Trump admin prepares new probe into U.S. pharma prices, FT says
- Cencora price target raised to $334 from $316 at Mizuho
- Cencora added to ‘Tactical Outperform’ list at Evercore ISI
- Cencora’s Long-Term Potential Outweighs Near-Term Challenges: A Buy Rating Despite Conservative Growth Guidance